PREP program for people with muscular dystrophy
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a program called PREP designed to help people with muscular dystrophy find ways to join in everyday activities. It aims to see if learning new strategies can improve your engagement and participation in life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with Duchenne or Becker muscular dystrophy (DBMD).
- You must be between 14 and 30 years old.
- You can be from any part of Israeli society.
- You cannot have already taken part in the PREP program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain and muscle scans, thinking tests, and muscle assessments to understand how the absence of the Dp140 protein affects people with Becker muscular dystrophy. You may be able to join if you have this condition, can walk, and are interested in helping doctors learn more.
This trial tests a 5-week digital breathing exercise program for children with Duchenne or Becker muscular dystrophy. It aims to improve lung function using simple exercises done at home.
This study collects electronic health records (medical information already in your doctor's computer system) from people with Duchenne or Becker muscular dystrophy, or female carriers of these conditions. Researchers will use this data to better understand the diseases and improve care over time.
This study tests a new medication called KER-065 to see if it helps people with Duchenne Muscular Dystrophy (DMD). It may help boys and men who are still walking, as well as those who use a wheelchair, as long as they are on a stable corticosteroid treatment.
This study collects information from patients with Duchenne or Becker muscular dystrophy to learn more about the conditions and improve care. You will share data through a telemedicine platform, and you need a smartphone or tablet to take part.
This trial tests a new daily pill called SAT-3247 for boys with Duchenne muscular dystrophy (DMD) who are still able to walk. The goal is to see if it can help slow muscle decline.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.